A study reveals a novel adhesive patch prototype using AgNP-Cx+ for enhanced anti-tumor activity against melanoma, showcasing significant therapeutic potential.
Innovative nanoflower-coated dressings demonstrate effective antibacterial and anti-inflammatory qualities, paving the way for advanced wound care solutions.
The development of LivGels at Penn State offers a breakthrough in biomaterials, mimicking ECMs for improved tissue repair and dynamic applications in science.
The creation of chiral materials from semiconductors at Cornell opens new avenues for optical sensors and displays, enhancing light interaction capabilities.
The 3D-printed brain-like model from TU Delft promotes structured neuronal networks, offering a new tool for investigating brain disorders like Alzheimer's.
The Au-HN-1 nanosystem represents a breakthrough in TSCC treatment, integrating targeted photothermal therapy with advanced imaging for precise tumor ablation.
According to a study published in Advanced Functional Materials on November 24th, 2024, a group of researchers led by Assistant Professor Andy Tay from the Department of Biomedical Engineering in the College of Design and Engineering and Institute of Health Innovation & Technology at NUS has created a novel way to improve the accuracy of cancer treatment using gold nanoparticles tagged with DNA barcodes.
An injectable hydrogel platform shows promise in local immunotherapy for triple-negative breast cancer, enhancing treatment efficacy with lower toxicity.
The Under-oil Open Microfluidic System enhances tumor cell-ECM interaction studies, improving anti-metastatic drug testing for triple-negative breast cancer.
A recent study evaluates the potential of Nanosota-EB1 and Nanosota-EB2, nanobody inhibitors targeting the Ebola virus. Findings suggest that these nanobodies could improve survival rates and reduce viral loads in infected mice, offering promising therapeutic avenues for Ebola virus disease.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.